AQR Capital Management’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-78,988
| Closed | -$240K | – | 3226 |
|
2024
Q4 | $240K | Sell |
78,988
-20,199
| -20% | -$61.4K | ﹤0.01% | 2599 |
|
2024
Q3 | $515K | Sell |
99,187
-101,893
| -51% | -$529K | ﹤0.01% | 2160 |
|
2024
Q2 | $517K | Buy |
201,080
+170,960
| +568% | +$439K | ﹤0.01% | 2040 |
|
2024
Q1 | $148K | Buy |
+30,120
| New | +$148K | ﹤0.01% | 2301 |
|
2023
Q3 | – | Sell |
-13,483
| Closed | -$341K | – | 2398 |
|
2023
Q2 | $341K | Sell |
13,483
-717
| -5% | -$18.1K | ﹤0.01% | 1900 |
|
2023
Q1 | $457K | Buy |
+14,200
| New | +$457K | ﹤0.01% | 1810 |
|
2021
Q4 | – | Sell |
-9,691
| Closed | -$270K | – | 2297 |
|
2021
Q3 | $270K | Hold |
9,691
| – | – | ﹤0.01% | 2063 |
|
2021
Q2 | $287K | Sell |
9,691
-6,517
| -40% | -$193K | ﹤0.01% | 2055 |
|
2021
Q1 | $453K | Sell |
16,208
-1,386
| -8% | -$38.7K | ﹤0.01% | 1872 |
|
2020
Q4 | $499K | Sell |
17,594
-2,547
| -13% | -$72.2K | ﹤0.01% | 1790 |
|
2020
Q3 | $506K | Buy |
20,141
+6,838
| +51% | +$172K | ﹤0.01% | 1716 |
|
2020
Q2 | $325K | Buy |
+13,303
| New | +$325K | ﹤0.01% | 1869 |
|
2018
Q4 | – | Sell |
-8,086
| Closed | -$201K | – | 2297 |
|
2018
Q3 | $201K | Sell |
8,086
-5,163
| -39% | -$128K | ﹤0.01% | 2194 |
|
2018
Q2 | $364K | Buy |
13,249
+39
| +0.3% | +$1.07K | ﹤0.01% | 2076 |
|
2018
Q1 | $407K | Buy |
13,210
+356
| +3% | +$11K | ﹤0.01% | 1970 |
|
2017
Q4 | $460K | Buy |
12,854
+2,463
| +24% | +$88.1K | ﹤0.01% | 1941 |
|
2017
Q3 | $286K | Buy |
+10,391
| New | +$286K | ﹤0.01% | 2092 |
|
2016
Q3 | – | Sell |
-12,073
| Closed | -$164K | – | 2303 |
|
2016
Q2 | $164K | Sell |
12,073
-3,114
| -21% | -$42.3K | ﹤0.01% | 2127 |
|
2016
Q1 | $265K | Buy |
15,187
+2,666
| +21% | +$46.5K | ﹤0.01% | 2037 |
|
2015
Q4 | $428K | Buy |
+12,521
| New | +$428K | ﹤0.01% | 1930 |
|